to commercially develop new pharmaceutical products and medicines and to offer its expertise to companies in the field of medical research. To achieve this goal, the company may, in particular: define, develop, finance and implement, alone or in partnership with third parties, research programs aimed at the development of pharmaceutical products; valorize, manage and commercially exploit products resulting from biomedical research, protected or not by patents, and grant any license rights for the exploitation of such products by third parties; define, develop, finance and implement, alone or in partnership with third parties, research programs and clinical trials aimed at developing the commercial potential inherent in discoveries or the acquisition of intellectual property rights; offer scientific analysis services covering health, environment, medicine and therapeutic development; acquire, administer and sell, directly or indirectly, participations in companies whose object is related to that pursued by the company.